Literature DB >> 20201343

[Ventilator-associated pneumonia after cardiac surgery].

Jadwiga Wójkowska-Mach1, Magda Baran, Rafał Drwiła, Ewelina Foryciarz, Agnieszka Misiewska-Kaczur, Dorota Romaniszyn, Piotr B Heczko.   

Abstract

BACKGROUND: Ventilator-associated pneumonia (VAP) is a common complication in intensive care patients. Patients are most likely to be affected after abdominal and thoracic surgery.
METHODS: The aim of the study was to analyze the epidemiology and aetiology of ventilator-associated pneumonia (VAP) following coronary artery surgery. Suspected cases were detected by the hospital Infection Control Team, in cooperation with ward personnel, and in accordance with CDC definitions.
RESULTS: Fifty-three VAP cases were detected among 2,170 cardiac surgery patients. The ventilator utilization rate was 52%.The total cumulative VAP incidence was 2.2%, and the ventilator-associated pneumonia rate was 18.3/1,000 ventilator days, with a mortality of 1.9%.The most common isolates were Gram negative bacteria (P aeruginosa--10.4%, E. coli--12.5%, Klebsiella pneumoniae--16.7%) and Candida albicans.
CONCLUSIONS: The incidence of VAP was similar to those reported in NHSN and KISS programs, however the data on the epidemiology of VAP were different. There were also differences in both the epidemiology and microbiology of VAP in this hospital, compared with results reported from other cardiac centres. This indicates the necessity of introducing an effective detection system for hospital acquired pneumonia after cardiac surgery.

Entities:  

Mesh:

Year:  2009        PMID: 20201343

Source DB:  PubMed          Journal:  Anestezjol Intens Ter        ISSN: 0209-1712


  1 in total

1.  Influence of Remifentanil/Propofol Anesthesia on Ventilator-associated Pneumonia Occurence After Major Cardiac Surgery.

Authors:  Alisa Krdzalic; Anita Kosjerina; Elmir Jahic; Zijah Rifatbegovic; Goran Krdzalic
Journal:  Med Arch       Date:  2013-12-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.